Sorrenti, S.; Malerba, S.; Lori, E.; Pironi, D.; Polom, K.; Skokowski, J.; Girnyi, S.; Cwalinski, T.; Prete, F.P.; Vashist, Y.K.;
et al. Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Gastric Signet-Ring Cell Carcinoma. Cancers 2025, 17, 2400.
https://doi.org/10.3390/cancers17142400
AMA Style
Sorrenti S, Malerba S, Lori E, Pironi D, Polom K, Skokowski J, Girnyi S, Cwalinski T, Prete FP, Vashist YK,
et al. Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Gastric Signet-Ring Cell Carcinoma. Cancers. 2025; 17(14):2400.
https://doi.org/10.3390/cancers17142400
Chicago/Turabian Style
Sorrenti, Salvatore, Silvia Malerba, Eleonora Lori, Daniele Pironi, Karol Polom, Jaroslaw Skokowski, Sergii Girnyi, Tomasz Cwalinski, Francesco Paolo Prete, Yogesh K. Vashist,
and et al. 2025. "Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Gastric Signet-Ring Cell Carcinoma" Cancers 17, no. 14: 2400.
https://doi.org/10.3390/cancers17142400
APA Style
Sorrenti, S., Malerba, S., Lori, E., Pironi, D., Polom, K., Skokowski, J., Girnyi, S., Cwalinski, T., Prete, F. P., Vashist, Y. K., Testini, M., & Marano, L.
(2025). Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Gastric Signet-Ring Cell Carcinoma. Cancers, 17(14), 2400.
https://doi.org/10.3390/cancers17142400
